Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1253484
Max Phase: Preclinical
Molecular Formula: C41H45N3O3
Molecular Weight: 627.83
Molecule Type: Small molecule
Associated Items:
ID: ALA1253484
Max Phase: Preclinical
Molecular Formula: C41H45N3O3
Molecular Weight: 627.83
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC(C)c1cc(-c2cc3c(CC(C)C)cc(-c4cc5c(C(C)C)cccc5nc4OC)cc3nc2OC)cc2nc(OC)ccc12
Standard InChI: InChI=1S/C41H45N3O3/c1-10-25(6)31-18-28(20-37-30(31)14-15-39(42-37)45-7)33-21-32-26(16-23(2)3)17-27(19-38(32)44-41(33)47-9)34-22-35-29(24(4)5)12-11-13-36(35)43-40(34)46-8/h11-15,17-25H,10,16H2,1-9H3
Standard InChI Key: CIGZJTJSUNJUNI-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 627.83 | Molecular Weight (Monoisotopic): 627.3461 | AlogP: 10.53 | #Rotatable Bonds: 10 |
Polar Surface Area: 66.36 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 2.83 | CX LogP: 11.68 | CX LogD: 11.68 |
Aromatic Rings: 6 | Heavy Atoms: 47 | QED Weighted: 0.15 | Np Likeness Score: -0.19 |
1. Broch S, Hénon H, Debaud AL, Fogeron ML, Bonnefoy-Bérard N, Anizon F, Moreau P.. (2010) Synthesis and biological activities of new di- and trimeric quinoline derivatives., 18 (19): [PMID:20800501] [10.1016/j.bmc.2010.07.029] |
Source(1):